Back to Carlyle Group Inc. Carlyle Group Inc.

PHATPHAT

Showing 8 of 14 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in PHATHOM PHARMACEUTICALS INC

Yes. Carlyle Group holds 3,496,808 shares of PHAT (Phathom Pharmaceuticals), worth $37.9M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Carlyle Group has held PHAT since Q1 2023, across 14 quarterly 13F filings. PHAT is 0.4% of Carlyle Group's reported 13F portfolio.

Current Value

$37.9M

Current Shares

3.5M

Total Value Change

-$25.2M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
3.5M
0.0%
$37.9M0.4%$10.85
0
2026-Q1
Unchanged
3.5M
0.0%
$38.8M0.4%$11.05
0
2025-Q4
Unchanged
3.5M
0.0%
$58M0.4%$16.92
0
2025-Q3
Unchanged
3.5M
0.0%
$41.1M0.9%$11.33
0
2025-Q2
Unchanged
3.5M
0.0%
$33.5M0.7%$9.74
0
2025-Q1
Unchanged
3.5M
0.0%
$21.9M0.6%$6.60
0
2024-Q4
Unchanged
3.5M
0.0%
$28.4M0.7%$8.00
0
2024-Q3
Unchanged
3.5M
0.0%
$63.2M6.6%$17.52
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used